Frederic Moll

Frederic Moll (born 1952) is a physician, medical device developer and entrepreneur, specializing in the field of medical robotics.

Early life and education Moll's mother and father were both pediatricians. He was raised in Seattle where he attended Lakeside School He also obtained an M.S. degree in business management from Stanford University.

Following its acquisition by Eli Lilly, Origin MedSystem became an operating company within Guidant in 1992. Moll served as medical director of Guidant's surgical division until 1995.

Moll left Intuitive Surgical in 2002 to become founder & CEO of Hansen Medical, which developed robotic systems for vascular and interventional electrophysiology procedures, and a robotically steered catheter sheath. Hansen Medical received Frost & Sullivan's Product Innovation Award in 2008 for US Image-Guided and Robotic Assisted Surgery Devices.

Moll was a board member of Mako Surgical until its sale in 2013. Auris Health's Monarch system is a diagnostic tool that uses robotic-assisted endoscopy. Its application in the earlier and more accurate diagnosis of lung cancer was approved by the FDA in 2018. Johnson & Johnson (J&J) announced its acquisition of Auris Health in February 2019;

In 2016, Moll joined the board of RefleXion, a medical equipment company developing a biologically guided radiation therapy system for cancer treatment.